Web Images Videos Maps News Shopping Gmail more »
Sign in
Scholar Home  
  Advanced Scholar Search
Scholar Preferences
Scholar Results 1 - 10 of about 101 related to Musso: Should Nonalcoholic Fatty Liver Disease Be Included in the Definition of Metabolic Syndrome?. (0.11 sec) 

Should Nonalcoholic Fatty Liver Disease Be Included in the Definition of Metabolic …

- diabetesjournals.org
G Musso, R Gambino, S Bo, B Uberti, G Biroli, G … - Diabetes Care, 2008 - Am Diabetes Assoc
OBJECTIVE—The ability of the Adult Treatment Panel III (ATP III) criteria of metabolic syndrome
to identify insulin-resistant subjects at increased cardiovascular risk is suboptimal, especially
in the absence of obesity and diabetes. Nonalcoholic fatty liver disease (NAFLD) is ...
Cited by 18 - Related articles - BL Direct - All 7 versions

Non-alcoholic fatty liver disease is strongly associated with carotid atherosclerosis: …


S Sookoian, CJ Pirola - Journal of Hepatology, 2008 - Elsevier
From a total of 3497 subjects (1427 patients and 2070 controls), we found a significant association
between NAFLD and carotid IMT either in fixed (D: 0.51, 95% CI: 0.44–0.58, p < 1 × 10 −8 ) or
random models (D: 1.44, CI: 95% 0.63–2.24, p < 0.0006). Meta-regression analysis ...
Cited by 17 - Related articles - All 22 versions

Nonalcoholic fatty liver disease is independently associated with an increased …


G Targher, L Bertolini, S Rodella, R Tessari, L … - Diabetes Care, 2007 - Am Diabetes Assoc
Recent data suggest that the presence of nonalcoholic fatty liver disease (NAFLD) in type 2 diabetes
may be linked to increased cardiovascular disease (CVD) independent of components of the
metabolic syndrome (1–3), although this hypothesis needs verification in larger studies. ...
Cited by 27 - Related articles - BL Direct - All 5 versions

Recent insights into hepatic lipid metabolism in non-alcoholic fatty liver disease ( …


G Musso, R Gambino, M Cassader - Progress in Lipid Research, 2009 - Elsevier
Nonalcoholic fatty liver disease (NAFLD) is the most common chronic liver disease in Western
countries and is considered the hepatic manifestation of metabolic syndrome. The hallmark of
NAFLD is hepatic neutral lipid accumulation, mainly triacylglycerol, in the absence of ...
Cited by 7 - Related articles - All 2 versions

Effect of Rimonabant on the High-Triglyceride/Low-HDL-Cholesterol Dyslipidemia, …

- nursing2008.com
JP Despres, R Ross, G Boka, N Almeras, I … - … , and vascular biology, 2008 - Am Heart Assoc
Kluwer Health, 351 West Camden Street, Baltimore, MD 21202-2436. Phone:
410-528-4050. Permissions: Permissions & Rights Desk, Lippincott Williams & Wilkins, a division
of Wolters ... Effect of Rimonabant on the High-Triglyceride/ ... Jean-Pierre Després, ...
Cited by 9 - Related articles - All 6 versions

Liver X receptor antagonist reduces lipid formation and increases glucose …


ET Kase, GH Thoresen, S Westerlund, K Højlund, AC … - Diabetologia, 2007 - Springer
Abstract Aims/hypothesis Liver X receptors (LXRs) play important roles in lipid and carbohydrate
metabolism. The purpose of the present study was to evaluate effects of the endogenous LXR
agonist 22-R-hydroxycholesterol (22-R-HC) and its stereo- isomer ...
Cited by 9 - Related articles - BL Direct - All 3 versions

Evaluation of metabolic syndrome frequency and carotid artery intima-media …


C Aygun, O Kocaman, T Sahin, S Uraz, AT Eminler, … - Digestive Diseases and …, 2008 - Springer
Page 1. ORIGINAL PAPER Evaluation of Metabolic Syndrome Frequency and Carotid
Artery Intima-media Thickness as Risk Factors for Atherosclerosis in Patients with
Nonalcoholic Fatty Liver Disease Cem Aygun Æ Orhan ...
Cited by 9 - Related articles - All 3 versions

Physiological differences between human and rat primary hepatocytes in response …

- aspetjournals.org
P Kotokorpi, E Ellis, P Parini, LM Nilsson, S Strom, … - Molecular Pharmacology, 2007 - ASPET
The liver is central to the maintenance of glucose and lipid homeostasis, and liver X receptors
(LXRs) are key regulators of expression of the genes involved. So far, effects of activation of LXR
in human hepatocytes have not been well characterized. Here we show that treatment of ...
Cited by 9 - Related articles - All 4 versions

[CITATION] Association between postprandial LDL conjugated dienes and the severity of liver …


G Musso, M Cassader, R Gambino, M … - Hepatology (Baltimore, …, 2006 - ncbi.nlm.nih.gov
1: Hepatology. 2006 May;43(5):1169-70. Comment on: Hepatology. 2005 Oct;42(4):974-5;
discussion 975. Association between postprandial LDL conjugated dienes and the severity of
liver fibrosis in NASH. Musso G, Cassader M, Gambino R, Durazzo M, Pagano G. ...
Cited by 9 - Related articles - BL Direct - All 3 versions

[CITATION] Rimonabant as a novel therapeutic option for nonalcoholic steatohepatitis


M Banasch, O Goetze, WE Schmidt, JJ Meier - Liver International, 2007 - interscience.wiley.com
It is also possible that your web browser is not configured or not able to display style sheets.
In this case, although the visual presentation will be degraded, the site should continue to be
functional. We recommend using the latest version of Microsoft or Mozilla web browser to ...
Cited by 12 - Related articles - BL Direct - All 3 versions


Result Page: 

1

2

3

4

5

6

7

8

9

10

Next


 


Go to Google Home - About Google - About Google Scholar

©2009 Google